CHAPTER 1 - MARKET SUMMARY
Market Overview
The Oman Medical Footwear Market links clinical referrals with retail and institutional purchasing. An estimated 412,300 adults aged 20-79 in Oman lived with diabetes in 2024. Within that population, assessed foot risk, prior ulceration, and footwear fit determine who may need therapeutic footwear. Suppliers therefore compete for access to clinicians and buyers who can identify the appropriate product and support follow-up.
Muscat is the main distribution hub. Medical supply retailers accounted for an estimated 35% of national sales in 2025, and a Muscat specialist offers foot-pressure assessment alongside footwear. Concentrating samples and fitting capacity in the capital can help suppliers cover more referrals with the same stock. Replenishing partner outlets outside Muscat can extend that reach without duplicating a full size range at every location.
Market Value
USD 10 million
Oman, 2025
Dominant Region
Muscat Governorate
2025
Dominant Segment
Diabetic Footwear
2025
Total Number of Players
60
Oman, 2025 estimate
Future Outlook
Oman’s market is projected to rise from USD 10 million in 2025 to USD 17 million in 2032, a value CAGR of 8.68% (2025-2032) following 7.23% (2020-2025). The base case assumes that more assessed patients complete a fitting, retailers replenish core sizes more frequently, and the product mix shifts toward extra-depth and custom-fitted footwear. Diabetes-related risk supports the demand pool, while referrals and affordability determine how much of that pool becomes paid demand. A supplier can monitor that conversion through completed fittings per referral, time to dispense, and the share of patients who return for replacements.
Volume is projected to reach 252,000 pair-equivalents in 2032 as specialist distribution widens and remote ordering makes it easier to replace a previously fitted model. First-time purchases and cases needing an individualized fit are more likely to use a clinic or specialist retailer. The forecast assumes selective adoption of premium products and incremental channel expansion. It treats broader reimbursement as an upside scenario. Oman's Dhamani platform provides a mechanism for exchanging health insurance transactions, while the benefit schedule for each policy determines what a buyer can claim.
8.68%
Forecast CAGR
USD 17 Mn
2032 Projection
Base Year
2025
Historical Period
2020-2025
Forecast Period
2025-2032
Historical CAGR
7.23% (2020-2025)
CHAPTER 2 - SCOPE OF REPORT
Scope of the Market
CHAPTER 3 - Key Stakeholders
Key Target Audience
Key stakeholders can use the market analysis for investment, strategy, and operational planning.
Investors
Gross margins, inventory turns, cash conversion, expansion economics
Corporates
Referral conversion, size coverage, price realization, channel economics
Government
Screening reach, geographic access, product compliance, procurement continuity
Operators
Fitting throughput, size fill rates, returns, replenishment lead times
Financial institutions
Working capital, stock aging, order concentration, cash collection
CHAPTER 4 - Market Size & Growth
Market Size, Growth Forecast and Trends
This section evaluates the historical market size, analyzes year-over-year growth dynamics, and presents forecast projections supported by market performance indicators and demand-side drivers. Market sizes are displayed to the nearest USD million. Growth and selling-price calculations use underlying model values, retained in the market-size cells.
Historical & Projected Market Size ($ Million)
Year-over-Year Growth Rate (%)
Market Value vs Volume Growth (%)
Historical Market Performance (2020-2025)
Modeled volume increased by 40,000 pair-equivalents over the historical period, a volume CAGR of 6.40% (2020-2025). The backcast places the trough in 2020 and the peak in 2025. Volume growth rose from 4.55% in 2021 to 7.38% in 2023 as the model assumes more clinic-led fitting and retail access after early-period disruption. The resulting trajectory is consistent with a category that relied on imported stock and physical fitting for new patients. The broad footwear import series provides historical context, while category-specific sales and the year-to-year recovery path remain modeled.
Forecast Market Outlook (2025-2032)
Market value reaches USD 17 million in 2032, a CAGR of 8.68% (2025-2032). Volume grows at 7.69% (2025-2032), while the implied average selling price rises from USD 63.33 in 2025 to USD 67.50 in 2032. The difference reflects a modest shift toward extra-depth and fitted products. Value growth peaks at 9.09% in 2030 within the supplied projection and settles near 8.7% annually in the final two years. Inventory planning should separate routine size replenishment from made-to-measure orders, where fitting time and cash tied up in work in progress affect profitability.
CHAPTER 5 - Market Data
Market Breakdown
The increase in unit demand supports a broader size range. Selling-price and product-mix projections help management assess whether the added stock and fitting capacity can earn their cost.
Year | Market Size (USD Mn) | YoY Growth (%) | Volume (Pair-Equivalents) | Implied ASP (USD per Pair-Equivalent) | Diabetic Footwear Revenue Mix (%) | Period |
|---|---|---|---|---|---|---|
| 2020 | $7 Mn | +Series opening year | 110,000 | 60.91 | Forecast | |
| 2021 | $7 Mn | +5.97% | 115,000 | 61.74 | Forecast | |
| 2022 | $8 Mn | +7.04% | 122,000 | 62.30 | Forecast | |
| 2023 | $8 Mn | +7.89% | 131,000 | 62.60 | Forecast | |
| 2024 | $9 Mn | +7.32% | 140,000 | 62.86 | Forecast | |
| 2025 | $10 Mn | +7.95% | 150,000 | 63.33 | Forecast | |
| 2026 | $10 Mn | +8.42% | 161,500 | 63.78 | Forecast | |
| 2027 | $11 Mn | +8.74% | 173,900 | 64.40 | Forecast | |
| 2028 | $12 Mn | +8.93% | 187,300 | 65.14 | Forecast | |
| 2029 | $13 Mn | +8.20% | 201,700 | 65.44 | Forecast | |
| 2030 | $14 Mn | +9.09% | 217,200 | 66.30 | Forecast | |
| 2031 | $16 Mn | +8.68% | 234,000 | 66.88 | Forecast | |
| 2032 | $17 Mn | +8.69% | 252,000 | 67.50 | Forecast |
Volume
reached an estimated 150,000 pair-equivalents in Oman in 2025. Avicen lists 43 pharmacy branches in Oman, illustrating how a chain can distribute core cast-shoe sizes and share replenishment stock across outlets.
Implied ASP
was USD 63.33 per pair-equivalent in Oman in 2025. The public medical-supplies directorate publishes a dedicated orthotic price list for 2023, making institutional pricing a separate benchmark when evaluating the margins available through tenders and specialist retail.
Diabetic Footwear Revenue Mix
reaches a modeled 49.0% in Oman in 2032. About half of Oman’s adult diabetes cases were estimated to be undiagnosed in 2024, so fitting capacity has the strongest near-term commercial case where clinics already reach diagnosed patients.
CHAPTER 6 - Segmentation
Market Segmentation Framework
Seven dimensions describe what buyers purchase, where they obtain it, and which clinical and commercial requirements shape the sale.
No of Segments
7
Dominant Segment
Product Type
Fastest Growing Segment
Distribution Channel
Product Type
Distribution Channel
Application
Customer Type
Fit Configuration
Price Tier
Geography
Key Segmentation Takeaways
The product and channel dimensions explain different decisions. Product choice determines fitting and inventory requirements, while channel choice determines how the buyer obtains the product.
Product Type
Diabetic Footwear leads by revenue because preventive extra-depth shoes create a replacement opportunity alongside individual offloading purchases. Risk assessment can determine whether buyers need deeper uppers, more width, or a pressure-relieving configuration. Retailers that can fill common sizes quickly are better positioned to convert referrals and retain repeat purchases once a wearer has established a suitable fit.
Distribution Channel
Cross-Border E-Commerce is the fastest-growing route in the model. Oman-facing platforms offer buyers a broader range of sizes and brands than many outlets can carry. The route is especially practical when the customer already knows the model and size. Online economics depend on managing failed deliveries, exchanges, and fit-related returns after allowing for platform fees.
CHAPTER 7 - Regional Analysis
Regional Analysis
Oman ranks fifth by modeled 2025 sales among the five GCC markets compared. Peer estimates use the same product scope and scale Oman's benchmark by diagnosed adult populations, with adjustments for purchasing power, specialist distribution, and adoption. The diagnosis measure indicates screening reach and provides context for addressable demand.
Regional Ranking
5th of 5 peers (2025)
Oman Market Size
USD 10 Mn (2025)
Oman CAGR
8.68% (2025-2032)
Regional Ranking
5th of 5 peers (2025)
Oman Market Size
USD 10 Mn (2025)
Oman CAGR
8.68% (2025-2032)
Regional Analysis (Current Year)
Regional Analysis Comparison
| Metric | Saudi Arabia | United Arab Emirates | Kuwait | Qatar | Oman |
|---|---|---|---|---|---|
| Market Size (USD Mn, 2025 / 2032F) | 112 / 197 | 34 / 63 | 21 / 36 | 11 / 20 | 10 / 17 |
| CAGR (%) | 8.40% (2025-2032) | 9.21% (2025-2032) | 8.00% (2025-2032) | 8.92% (2025-2032) | 8.68% (2025-2032) |
Market Position
Oman ranks fifth at USD 10 million in 2025. Qatar has a similar adult diabetes population but a higher diagnosed share, which supports a slightly larger modeled footwear market.
Growth Advantage
Oman’s 8.68% CAGR (2025-2032) exceeds Saudi Arabia’s 8.40% (2025-2032) and trails the UAE’s 9.21% (2025-2032). In Oman, adoption grows as specialist fitting reaches more referred patients.
Competitive Strengths
The UAE corridor supplied 51% of Oman’s 2023 leather-upper footwear imports. Muscat adds local foot-pressure assessment, letting suppliers pair consolidated stock sourcing with fitting for patients who need it.
CHAPTER 8 - INDUSTRY ANALYSIS
Growth Drivers, Challenges & Opportunities
Clinical demand, access to fitting, and dependable stocking determine how much of the potential patient population becomes recurring footwear revenue.
Growth Drivers
Diabetic Foot Risk and Repeat Purchases
- A crude prevalence of 13.2% among adults aged 20-79 (Oman, 2024) supports referral partnerships where clinicians can screen for the subset requiring therapeutic footwear.
- The 2023 ulcer-prevention guideline recommends footwear with a demonstrated pressure-relieving effect for eligible patients with a healed plantar ulcer. Vendors can compete on documented performance and follow-up.
- The 2023 offloading guideline separates active-ulcer offloading from routine prevention. Separate purchasing pathways help clinics stock the right products and limit inappropriate substitutions.
Older Patients and Musculoskeletal Demand
- The reported 4% annual increase in the older population (Oman, 2025) supports investment in fittings for patients who need accessible closures and wider size options.
- The Omani public orthotic price list (2023) gives suppliers a procurement reference for building separate institutional and cash-pay offers.
- Local custom foot orthosis services in Muscat show that fitting expertise exists. Footwear suppliers can partner with those practices when the orthosis and shoe are sold as one product.
More Routes to Purchase
- Oman-facing medical shoe listings let patients reorder known sizes online and give distributors a route to carry less common sizes centrally.
- Muscat-based foot-pressure assessment gives specialist retailers a service that can convert complex referrals into fitted orders and reduce exchanges.
- Oman’s orthotic procurement listings give suppliers an institutional route alongside retail. A separate assortment can protect consumer availability during large orders.
Market Challenges
Diagnosis and Referral Gaps
- The gap between total and diagnosed diabetes cases (Oman, 2024) makes clinic attendance and screening outcomes better stocking inputs than national prevalence alone.
- The 2023 prevention guideline’s risk categories imply different footwear needs. Broad stocking without clinic-level case information increases the chance of holding slow-moving products.
- Oman’s Arabic-language diabetic foot education gives clinics material for counseling patients. Retail conversion still depends on directing suitable patients to a fitting they can access.
Import Concentration and SKU Compliance
- The UAE’s leading position in Oman’s 2023 HS 6403 imports makes consolidated buying efficient, but reliance on one corridor can lengthen stockouts if a wholesaler runs short.
- The 2025 controlled-products update requires importers to align documentation with the current tariff list. Incomplete SKU files can delay the first shipment and tie up launch capital.
- Oman provides a medical-device and supplies registration service. Suppliers can stage launch spending once the route for each applicable SKU is confirmed.
Affordability and Uncertain Reimbursement
- The public orthotic price list (Oman, 2023) provides a tender benchmark. Retailers must account separately for fitting labor, exchanges, and patient service in their prices.
- Oman-facing marketplace listings expose buyers to a broad price range. Specialist sellers need to explain which features and fitting services justify the total purchase price.
- The 2023 diabetic ulcer-prevention guideline emphasizes consistent use of recommended footwear in relevant cases. Fit dissatisfaction and replacement cost can undermine repeat sales.
Market Opportunities
Clinic-to-Retail Diabetic Foot Pathways
- Where foot-pressure assessment is already offered in Muscat, a supplier can sell a fitted footwear package and track its conversion per appointment.
- Clinics and specialist distributors benefit from a standard referral handoff aligned with the 2023 prevention guideline’s risk assessment approach.
- Referrals need product and fit criteria that distinguish preventive shoes from the devices indicated under the 2023 active-ulcer offloading guideline.
Pharmacy Stocking for Recovery Footwear
- Chain buyers can use the 43-branch Avicen network as a reference for pooling slow-moving sizes at a hub and replenishing high-volume outlets.
- Discharge teams and pharmacies can share fit and pickup information using size ranges like the small and extra-large cast-shoe SKUs listed in Oman.
- A rollout needs confirmed tariff and documentation handling for each model under the Oman controlled-products update (2025).
Digital Reordering of Fitted Models
Oman-facing therapeutic footwear listings
- Sellers can offer replacement orders against a saved fitting record. Oman online listings with model-level sizing show how retailers can make the same SKU easy to identify.
- Specialist outlets can retain the fitting relationship while using domestic pharmacy delivery infrastructure as a reference for lower-cost repeat fulfillment.
- Online sellers need a way to route changed foot shape or risk back to reassessment, consistent with the 2023 preventive care guidance.
CHAPTER 9 - Competitive Landscape
Competitive Landscape Overview
Specialist importers compete with pharmacy chains and online sellers. Local fitting and ready stock create barriers to entry. The profiles distinguish modeled Oman sales shares from observed product availability.
Market Share Distribution
Top 5 Players
Market Dynamics
8 new entrants in the past 5 years, indicating strong market attractiveness and growth potential.
Company Name | Market Share | Headquarters | Founding Year | Core Market Focus |
|---|---|---|---|---|
HUI Medical Supplies (MuscatMed) | 10.5% (2025 estimate) | Muscat, Oman | 2018 | Offloading and postoperative shoes, with local fitting. |
Al Farsi Medical Supplies | 8.4% (2025 estimate) | Muscat, Oman | 2008 | Orthopedic supply and fitting, with in-scope footwear sales estimated in the sizing brief. |
Noon | 6.3% (2025 sales through platform, estimated) | - | - | Oman-facing marketplace for medical and postoperative shoes. |
Modern Care Medical Equipment Center | 3.7% (2025 estimate) | Seeb, Oman | - | Medical equipment retail, with therapeutic footwear participation estimated in the sizing brief. |
Sky Moon Medical Supplies | 0.8% (2025 estimate) | Muscat, Oman | 2004 | Medical-supply distribution, with footwear participation estimated in the sizing brief. |
Avicen Pharmacy | - | - | - | Local pharmacy channel for rocker-sole cast shoes. |
Tynor | - | - | - | Cast-shoe brand carried by an Oman pharmacy retailer. |
OrthoComfoot | - | - | - | Wide-fit orthopedic and diabetic footwear listed for Oman. |
Desertcart | - | - | - | Cross-border retail listings for diabetic and orthopedic footwear. |
Ubuy | - | - | - | Cross-border listings for wide-fit therapeutic shoes. |
Cross Comparison Parameters
The report provides detailed cross-comparison of key players across 10 performance parameters to identify competitive strengths and weaknesses.
Core Size Fill Rate
Fit-Related Return Rate
Net Footwear Revenue per Pair
Gross Margin per Pair
Analysis Covered
Market Share Analysis:
Compares estimated domestic sales shares across profiled distributors and channels.
Cross Comparison Matrix:
Benchmarks inventory availability, fit-related returns, realized revenue, and unit margins.
SWOT Analysis:
Assesses fitting capability, procurement exposure, local reach, and online competition.
Pricing Strategy Analysis:
Compares realized prices after channel discounts, delivery, and return costs.
Company Profiles:
Documents local routes to market, product focus, and available facts.
CHAPTER 10 - REPORT TOC
Table of Contents
Market Assessment Phase
Supply-side and competitive intelligence covering market sizing, segmentation, competitive dynamics, regulatory landscape, and future forecasts.
Go-To-Market Strategy Phase
15 chapters
Entry strategy evaluation, execution roadmap, partner recommendations, and profitability outlook.
Survey Phase
8 chapters
Demand-side primary research conducted through structured interviews and online surveys with end users across priority metros and Tier 2/3 cities to capture consumption behavior, unmet needs, and purchase drivers.
Complete Report Coverage
201+ detailed sections covering every aspect of the market
143
Assessment Sections
58
Strategy Sections
CHAPTER 11 - Our Approach
Research Methodology
Desk Research
- Review Oman diabetic foot indicators
- Map footwear imports by heading
- Audit clinical footwear product listings
- Compare retail and tender assortments
Primary Research
- Plan interviews with procurement managers
- Recruit podiatrists and clinical orthotists
- Screen footwear category buying teams
- Target licensed pharmacy purchasing managers
Validation and Triangulation
- Design validation for 250 respondents
- Check final sales against shipments
- Reconcile fit-adjusted selling price assumptions
- Compare diagnoses with referral volumes
CHAPTER 12 - FAQ
FAQs
Still have questions?
Our research team is here to help you find the right solution
CHAPTER 13 - Related Research
Explore Related Reports
Expand your market intelligence with complementary research across regions and adjacent markets.
Regional/Country ReportsRelated market analysis across key regions
Related market analysis across key regions
No regional reports found.
Adjacent ReportsRelated markets and complementary research
Related markets and complementary research
- Vietnam Diabetic Foot Care Market
- Germany Orthopedic Footwear Market
- South Africa Medical Device Distribution Market
- KSA Foot Pressure Analysis Technology Market
- Qatar Custom Orthotics Market
500+
Market Research Reports
50+
Countries Covered
15+
Industry Verticals